Seres Therapeutics, Inc.MCRBNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank38
3Y CAGR-62.4%
5Y CAGR-23.2%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-62.4%/yr
Annual compound
5Y CAGR
-23.2%/yr
Recent deceleration
Percentile
P38
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.98 | -68.2% |
| 2024 | 9.37 | +334.5% |
| 2023 | -4.00 | -107.1% |
| 2022 | 56.13 | +866.3% |
| 2021 | 5.81 | -48.1% |
| 2020 | 11.19 | +376.6% |
| 2019 | -4.04 | -5.5% |
| 2018 | -3.83 | -156.7% |
| 2017 | 6.76 | +127.2% |
| 2016 | 2.97 | - |